GVHD-derived plasma as a priming strategy of mesenchymal stem cells

BACKGROUND: Mesenchymal stem cell (MSC) therapy is an important alternative for GVHD treatment, but a third of patients fail to respond to such therapy. Therefore, strategies to enhance the immunosuppressive potential of MSCs constitute an active area of investigation. Here, we proposed an innovativ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cell Res Ther
Main Authors: Silva-Carvalho, Amandda Évelin, Rodrigues, Leane Perim, Schiavinato, Josiane Lilian, Alborghetti, Marcos Rodrigo, Bettarello, Gustavo, Simões, Belinda Pinto, Neves, Francisco de Assis Rocha, Panepucci, Rodrigo Alexandre, de Carvalho, Juliana Lott, Saldanha-Araujo, Felipe
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7164240/
https://ncbi.nlm.nih.gov/pubmed/32299501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01659-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados